(Reuters) - Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey ...

As with other medications, Humira can interact with certain other drugs. It can also interact with some vaccines. An interaction occurs when one substance causes another substance to have a different ...

Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a blockbuster, appears to have led to a dramatic drop in net spending for these ...

Celltrion USA’s FDA-approved biosimilar adalimumab-aaty, has been added program to the Costco member prescription program. Adalimumab-aaty is a high-concentration (100mg/mL) and citrate-free ...

The price you pay for Amjevita may depend on factors such as the form you’re prescribed and whether you have health insurance. Financial assistance may be available to help you with the cost of ...

Cigna's pharmacy benefit manager business, Express Scripts, will exclude AbbVie's Humira from its largest commercial formularies. The wildly successful biologic drug for inflammatory conditions, such ...

AbbVie’s popular arthritis drug Humira is a powerhouse, producing $14 billion in annual sales to make up 60 percent of the drugmaker’s revenue. However, generic versions of the drug are around the ...

Amgen on Thursday settled a patent lawsuit with Abbvie over its biosimilar version of Abbvie’s best-selling arthritis drug Humira, reports Reuters. The settlement will delay the launch of Amgen’s ...